1. Home
  2. IBN vs BMY Comparison

IBN vs BMY Comparison

Compare IBN & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICICI Bank Limited

IBN

ICICI Bank Limited

HOLD

Current Price

$30.43

Market Cap

107.0B

Sector

Finance

ML Signal

HOLD

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

HOLD

Current Price

$60.14

Market Cap

114.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBN
BMY
Founded
1955
1887
Country
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.0B
114.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IBN
BMY
Price
$30.43
$60.14
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
$59.93
AVG Volume (30 Days)
6.2M
11.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.69%
4.22%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.51
N/A
P/E Ratio
$18.86
$17.26
Revenue Growth
N/A
N/A
52 Week Low
$27.46
$42.52
52 Week High
$34.57
$63.33

Technical Indicators

Market Signals
Indicator
IBN
BMY
Relative Strength Index (RSI) 48.51 63.16
Support Level $30.52 $59.25
Resistance Level $31.68 $61.30
Average True Range (ATR) 0.46 1.41
MACD 0.01 0.07
Stochastic Oscillator 50.59 77.20

Price Performance

Historical Comparison
IBN
BMY

About IBN ICICI Bank Limited

ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.

About BMY Bristol-Myers Squibb Company

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: